[SLAM family proteins as therapeutic targets in multiple myeloma].

Tamura, Hideto; Ishibashi, Mariko; Takahashi, Hidemi; Inokuchi, Koiti

Tamura, Hideto; Ishibashi, Mariko; Takahashi, Hidemi; Inokuchi, Koiti.

Affiliation

Tamura H; Department of Hematology, Nippon Medical School.
Ishibashi M; Department of Microbiology and Immunology, Nippon Medical School.
Takahashi H; Department of Microbiology and Immunology, Nippon Medical School.
Inokuchi K; Department of Hematology, Nippon Medical School.

Rinsho Ketsueki ; 61(7): 818-826, 2020.

Article in Ja | MEDLINE | ID: mdl-32759570

Subject(s)

Multiple Myeloma; Antibodies, Monoclonal; Humans; Immunotherapy; Signaling Lymphocytic Activation Molecule Family Member 1

Key words

Antibody drug conjugate; Immunotherapy; Multiple myeloma; SLAM family molecules

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: Ja Journal: Rinsho Ketsueki Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google